Pfizer’s COVID-19 vaccine gets full FDA approval next week


The Food and Drug Administration is expected to give full approval to the Pfizer-BioNTech coronavirus vaccine early next week, sources told Axios on Friday.

Important reason: This will be the first COVID-19 shot to be fully approved by the federal government.

Get the right market news for your time at Axios Markets. Subscribe for free.

Big picture: The United States is currently fighting the resurgence of the virus. More contagious delta variant..Biden administration Said Fully vaccinated Americans earlier this week should expect booster shots to be offered eight months after launching their second shot in September.

  • “Approving the vaccine and encouraging boosters at the same time may suggest that the approved vaccine is inadequate without additional shots.” The New York Times writes..

In numbers: According to data from, 51.2% of the entire American population is fully vaccinated Centers for Disease Control and Prevention..

  • According to the CDC, more than 37 million cases of the virus have been identified in the United States and more than 624,000 have died.

More Axios Information: Sign up to get the latest market trends at Axios Markets. Subscribe for free